This live webinar has already taken place, however the archived presentation is still available for you to review »View Presentation
Clinical validation, high development costs and comparatively low market reimbursement rates present challenges for realizing personalized medicine and bringing value-based companion diagnostic and medical diagnostic tests to market. Gaining the acknowledgment of the "value" in these tests from both drug developers and payors is essential, and a number of strategies have emerged to bring these vital tests to market.
Learn about value-based diagnostics and why they are prominent in personalized medicine
Hear how VeriStrat® helps oncologists make treatment decisions in the 2nd line advanced NSCLC setting
Learn how value-based companion diagnostics enable personalized medicine
Get a look at new business models that can bring value-based CDx to personalized medicine
Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease.
August 6-8, 2012 · San Francisco, CA
A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:
Presenter: Paul Bereford, PhD, Vice President, Business Development and Strategic Marketing, Biodesix
Paul Beresford is currently the Vice President, Business Development and Strategic Marketing at Biodesix. Prior to Biodesix he was Vice President and General Manager of Translational Diagnostics at Ventana Medical Systems/Roche for eight years.
A New Vision for the Drug-Diagnostic Value Paradigm: Bringing Personalized Medicine to Market
Tuesday, April 10, 2012
2:00 pm (EDT)
3:00 pm (EDT)
After registering you will receive a confirmation email containing information about joining the Webinar.
Required: Windows® 7, Vista, XP or 2003 Server
Mac OS® X 10.5 or newer
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: email@example.com